Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect
Sponsored by New York University
About this trial
Last updated a month ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Starts in 4 months
What is this trial about?
What are the participation requirements?
Inclusion Criteria
1. Diagnosis of childhood apraxia of speech (CAS). The diagnosis will be made by two speech language pathologists (SLPs) who have extensive experience in the differential diagnosis of CAS.
2. Age between 3;6 and 12;11 years.
3. Normal structure of the oral-peripheral mechanism as determined by a motor speech examination using established lab protocol.
4. Participants must pass a hearing screening conducted at 20 dB SPL at 500, 1000, 2000 and 4000 Hz.
5. Not receiving speech treatment elsewhere over the course of this study, although language, augmentative and alternative communication (AAC) treatment, or similar non-speech treatment, would be permitted.
6. Language Testing: Receptive Language Index standard score greater than or equal to 70 on the Clinical Evaluation of Language Fundamentals - Preschool 3rd edition (CELF-P3) for children 3;6-5;11 years of age, or the Clinical Evaluation of Language Fundamentals - 5th edition (CELF-5) for children 6;0-12;11 years of age.
7. Nonverbal Cognition Testing: Standard score greater than or equal to 70 on the Developmental Assessment of Young Children-2nd edition (DAYC-2) for children 3;6- 5;11 years of age, or the Reynolds Intellectual Assessment Scales- 2nd edition, Remote (RIAS) for children 6;0-12;11 years old.
8. Evidence of multi-word spontaneous speech up to five syllables in length.
9. English as the primary language.
Exclusion Criteria
1. Primary dysarthria diagnosis, even if CAS is a secondary diagnosis.
2. Abnormal structure of the oral peripheral mechanism.
3. Fluency disorder, even if the child meets criteria for CAS.
4. Conductive or sensorineural hearing loss, even if the child meets criteria for CAS.
5. English is not the primary language.
